Stephens Inc Biomarin Pharmaceutical Inc Transaction History

Stephens Inc

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 04, 2022	SELL	$74.28 - $92.69 $197,956 - $247,018	-2,665 Closed	0 $0
Q4 2021 Mar 07, 2022	SELL	$71.72 - $91.47 $37,796 - $48,204	-527 Reduced 16.51%	2,665 $235,000
Q3 2021 Oct 27, 2021	SELL	$74.77 - $85.47 $30,580 - $34,957	-409 Reduced 11.36%	3,192 $247,000
Q2 2021 Aug 12, 2021	BUY	$75.51 - $84.79 $22,350 - $25,097	296 Added 8.96%	3,601 $300,000
Q1 2021 May 14, 2021	SELL	$74.73 - $90.69 $63,445 - $76,995	-849 Reduced 20.44%	3,305 $250,000
Q4 2020 Feb 10, 2021	SELL	$72.61 - $90.2 $16,990 - $21,106	-234 Reduced 5.33%	4,154 $364,000
Q3 2020 Nov 13, 2020	BUY	$71.87 - $131.03 $11,427 - $20,833	159 Added 3.76%	4,388 $334,000
Q2 2020 Aug 24, 2020	SELL	$79.55 - $124.22 $55,446 - $86,581	-697 Reduced 14.15%	4,229 $522,000
Q1 2020 May 14, 2020	SELL	$71.37 - $96.85 $3,996 - $5,423	-56 Reduced 1.12%	4,926 $416,000
Q4 2019 Feb 14, 2020	BUY	$64.27 - $86.37 $53,472 - $71,859	832 Added 20.05%	4,982 $421,000
Q3 2019 Oct 18, 2019	SELL	$67.4 - $85.11 $6,066 - $7,659	-90 Reduced 2.12%	4,150 $280,000
Q2 2019 Aug 01, 2019	BUY	$80.35 - $93.9 $77,618 - $90,707	966 Added 29.51%	4,240 $363,000
Q1 2019 May 03, 2019	SELL	$84.2 - $98.62 $13,977 - $16,370	-166 Reduced 4.83%	3,274 $291,000
Q4 2018 Feb 11, 2019	BUY	$80.14 - $106.07 $23,721 - $31,396	296 Added 9.41%	3,440 $293,000
Q3 2018 Nov 14, 2018	BUY	$93.92 - $105.72 $295,284 - $332,383	3,144 New	3,144 $305,000

635

178M

2.01M

1.28M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $11.8B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Stephens Inc , based on Form 13F filings with the SEC.

Stay updated on Stephens Inc with notifications on news.